ARTICLE | Company News
Teijin receives Japanese rights to Pulmagen's asthma product
September 27, 2012 1:09 AM UTC
Pulmagen Therapeutics Ltd. (Slough, U.K.) granted Teijin Pharma Ltd. (Tokyo, Japan) exclusive rights in Japan to develop and commercialize asthma product ADC3680. Teijin plans to start Phase I testing...